New Market Perspective
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

New Market Perspective

Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

by admin December 20, 2024
December 20, 2024
RAD 202 receives approval to start Phase 1 therapeutic trial

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

0
FacebookTwitterGoogle +Pinterest
previous post
Westgold Shares Scoping Study for Expansion of Fortnum Gold Operation
next post
PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx Addressing Patients with Recurrent Pericarditis

Related Posts

Resolution Minerals LtdTo Develop U.S. Government Engagement Strategy...

June 18, 2025

Crypto Market Forecast: Top Trends That Will Affect...

December 29, 2023

Matthew Piepenburg: Gold, Markets and Debt in 2025...

January 30, 2025

Charbone Hydrogen Announces Q1 2025 Financial Results

May 31, 2025

BlinkLab Limited: Transforming Mental Healthcare through Mobile-based AI...

February 29, 2024

Allied Critical Metals Appoints Vitor Arezes as Vice...

June 24, 2025

Gold Price Update: Q1 2024 in Review

April 16, 2024

New INNspired Article Spotlights Rare Earth Recycling as...

June 12, 2025

Stardust Power Inc. Appoints Carlos Urquiaga as Senior...

April 8, 2025

Successful Completion of $24M Placement

August 2, 2024

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    • White House reveals highest-paid staffers–and 8 taking no salaries

      July 3, 2025

    • Trump $3.3T megabill sets House record for longest vote in history

      July 3, 2025

    • Iran nuclear program set back 2 years after US strikes: Pentagon

      July 3, 2025

    • Airlines secretly sold US travelers’ data to Homeland Security

      July 3, 2025

    • White House reveals highest-paid staffers – and 8 taking no salaries

      July 3, 2025

    • Jeffries stalls Trump’s ‘big, beautiful bill’ for hours after House GOP mutiny breakthrough

      July 3, 2025

    Popular

    • 1

      Top 5 Junior Copper Stocks on the TSXV in 2023

      December 22, 2023
    • 2

      Crypto Market 2023 Year-End Review

      December 22, 2023
    • 3

      Canada Silver Cobalt Begins Drilling at Lowney-Lac Edouard in Quebec, Targeting Nickel-Copper-Cobalt Mineralization

      December 22, 2023
    • 4

      10 Top Oil-producing Countries (Updated 2024)

      October 19, 2024
    • 5

      Top 10 Uranium-producing Countries (Updated 2024)

      April 18, 2024
    • 6

      Powered by rain, this seed carrier could help reforest the most remote areas

      December 19, 2023
    • 7

      A troubling theory about traders profiting from Hamas’ attack on Israel drew much attention. Why it may not be so simple.

      December 13, 2023

    Categories

    • Business (1,397)
    • Investing (3,435)
    • Politics (4,507)
    • World (4,410)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: newmarketperspective.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 newmarketperspective.com | All Rights Reserved